These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19815032

  • 1. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
    Dencker D, Husum H.
    Behav Brain Res; 2010 Feb 11; 207(1):78-83. PubMed ID: 19815032
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
    Redrobe JP, Nielsen AN.
    Behav Brain Res; 2009 Mar 17; 198(2):481-5. PubMed ID: 19162078
    [Abstract] [Full Text] [Related]

  • 4. Morphine sensitization as a model of mania: comparative study of the effects of repeated lithium or carbamazepine administration.
    Grappi S, Marchese G, Secci ME, De Montis MG, Gambarana C, Scheggi S.
    Pharmacol Biochem Behav; 2011 Oct 17; 99(4):749-58. PubMed ID: 21741986
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
    Lan A, Einat H.
    Behav Brain Res; 2019 Apr 19; 362():109-113. PubMed ID: 30630015
    [Abstract] [Full Text] [Related]

  • 8. Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
    Macêdo DS, Medeiros CD, Cordeiro RC, Sousa FC, Santos JV, Morais TA, Hyphantis TN, McIntyre RS, Quevedo J, Carvalho AF.
    Bipolar Disord; 2012 Nov 19; 14(7):707-18. PubMed ID: 22897629
    [Abstract] [Full Text] [Related]

  • 9. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
    Corrêa C, Amboni G, Assis LC, Martins MR, Kapczinski F, Streck EL, Quevedo J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):887-91. PubMed ID: 17367908
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amphetamine sensitization in mice is sufficient to produce both manic- and depressive-related behaviors as well as changes in the functional connectivity of corticolimbic structures.
    Pathak G, Ibrahim BA, McCarthy SA, Baker K, Kelly MP.
    Neuropharmacology; 2015 Aug 09; 95():434-47. PubMed ID: 25959066
    [Abstract] [Full Text] [Related]

  • 12. Sensitization, kindling, and anticonvulsants in mania.
    Post RM, Weiss SR.
    J Clin Psychiatry; 1989 Dec 09; 50 Suppl():23-30; discussion 45-7. PubMed ID: 2689434
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
    Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J.
    J Psychiatry Neurosci; 2006 Sep 09; 31(5):326-32. PubMed ID: 16951735
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.
    Einat H, Yuan P, Szabo ST, Dogra S, Manji HK.
    Neuropsychobiology; 2007 Sep 09; 55(3-4):123-31. PubMed ID: 17641532
    [Abstract] [Full Text] [Related]

  • 17. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Kalinichev M, Dawson LA.
    Int J Neuropsychopharmacol; 2011 Sep 09; 14(8):1051-67. PubMed ID: 21208504
    [Abstract] [Full Text] [Related]

  • 18. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
    Einat H.
    Pharmacol Rep; 2014 Aug 09; 66(4):722-5. PubMed ID: 24948079
    [Abstract] [Full Text] [Related]

  • 19. Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors.
    Zhou Z, Wang Y, Tan H, Bharti V, Che Y, Wang JF.
    Neurosci Lett; 2015 Aug 31; 603():84-8. PubMed ID: 26219985
    [Abstract] [Full Text] [Related]

  • 20. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
    Jornada LK, Moretti M, Valvassori SS, Ferreira CL, Padilha PT, Arent CO, Fries GR, Kapczinski F, Quevedo J.
    J Psychiatr Res; 2010 Jun 31; 44(8):506-10. PubMed ID: 19954800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.